ACTIV

July 26, 2021

VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

By Craig Boerner
David Haas, MD, and Beverly Woodward, MSN, RN, are shown in a procedure room in VUMC’s Communicable Disease Response Unit. The room contains state-of-the-art infection prevention features and opens directly to the outside.
September 2, 2020

VUMC launches clinical trial of outpatient treatments for COVID-19

Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.

By Leigh MacMillan
Gordon Bernard (Steve Green/Vanderbilt)
June 24, 2020

VICTR named to key role to streamline COVID-19 research response

The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.

By Bill Snyder